Aveanna Healthcare Holdings, Inc.: Form 10-Q for the period ended Jun 28, 2025
Filed with the SEC on Aug 7, 2025 and accepted by EDGAR at Aug 7, 2025, 10:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-06-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-03-30 to 2025-06-28 | $589.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2024-12-29 to 2025-06-28 | $1.15bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Gross profit | 3 months2025-03-30 to 2025-06-28 | $210.8m | us-gaap:GrossProfit |
| Gross profit | 6 months2024-12-29 to 2025-06-28 | $394.4m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2025-03-30 to 2025-06-28 | $90.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2024-12-29 to 2025-06-28 | $181.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-03-30 to 2025-06-28 | $80.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2024-12-29 to 2025-06-28 | $131.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-03-30 to 2025-06-28 | $36.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2024-12-29 to 2025-06-28 | $72.3m | us-gaap:InterestExpense |
| Income tax | 3 months2025-03-30 to 2025-06-28 | $17.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2024-12-29 to 2025-06-28 | $22.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-03-30 to 2025-06-28 | $27.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2024-12-29 to 2025-06-28 | $32.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-03-30 to 2025-06-28 | $0.13 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2024-12-29 to 2025-06-28 | $0.16 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-03-30 to 2025-06-28 | $0.13 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2024-12-29 to 2025-06-28 | $0.16 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-03-30 to 2025-06-28 | 210,442,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2024-12-29 to 2025-06-28 | 206,763,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2024-12-29 to 2025-06-28 | $42.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2025-06-28 | $100.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-06-28 | $449.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-06-28 | $1.77bn | us-gaap:Assets |
| Current liabilities | At period end2025-06-28 | $414.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-06-28 | $1.78bn | us-gaap:Liabilities |
| Long-term debt | At period end2025-06-28 | $1.27bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2025-06-28 | $9.2m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-06-28 | −$12.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-25-104528. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.